SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced that Jeffrey Jonas, M.D., chief executive officer, is scheduled to present a company overview and update at the 32nd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014 at 9:00 a.m. PT. The conference is being held January 13-16, 2014 at the Westin St. Francis Hotel in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
